Polymalic acid-based nanobiopolymer provides efficient systemic breast cancer treatment by inhibiting both HER2/neu receptor synthesis and activity. - Wikidata - awgldk - TriplyDB

Polymalic acid-based nanobiopolymer provides efficient systemic breast cancer treatment by inhibiting both HER2/neu receptor synthesis and activity.

Polymalic acid-based nanobiopolymer provides efficient systemic breast cancer treatment by inhibiting both HER2/neu receptor synthesis and activity.

http://www.wikidata.org/entity/Q36191573

about

Nanobiopolymer for direct targeting and inhibition of EGFR expression in triple negative breast cancer Marked enhancement of lysosomal targeting and efficacy of ErbB2-targeted drug delivery by HSP90 inhibition MRI Virtual Biopsy and Treatment of Brain Metastatic Tumors with Targeted Nanobioconjugates: Nanoclinic in the Brain NIH workshop report on the trans-agency blood-brain interface workshop 2016: exploring key challenges and opportunities associated with the blood, brain and their interface.Toxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment.Dual-pH Sensitive Charge-reversal Nanocomplex for Tumor-targeted Drug Delivery with Enhanced Anticancer Activity Biocompatible nanopolymers: the next generation of breast cancer treatment?Polymalic acid-based nano biopolymers for targeting of multiple tumor markers: an opportunity for personalized medicine?HER2-positive advanced breast cancer: optimizing patient outcomes and opportunities for drug development.One-pot Synthesis of Functional Poly(amino ester sulfide)s and Utility in Delivering pDNA and siRNA Cellular delivery of doxorubicin via pH-controlled hydrazone linkage using multifunctional nano vehicle based on poly(β-l-malic acid)The transferrin receptor and the targeted delivery of therapeutic agents against cancer.Multi-arm polymeric nanocarrier as a nitric oxide delivery platform for chemotherapy of head and neck squamous cell carcinoma.Current development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatment.Targeted polymeric therapeutic nanoparticles: design, development and clinical translation Therapeutic siRNA for drug-resistant HER2-positive breast cancer.Cellular iron metabolism in prognosis and therapy of breast cancer.Polymalic acid nanobioconjugate for simultaneous immunostimulation and inhibition of tumor growth in HER2/neu-positive breast cancer.Nanoscale particulate systems for multidrug delivery: towards improved combination chemotherapy.Natural and synthetic poly(malic acid)-based derivates: a family of versatile biopolymers for the design of drug nanocarriers.Strategies for overcoming the blood-brain barrier for the treatment of brain metastases.Strategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics.Antibody-targeted biodegradable nanoparticles for cancer therapy.Targeted nanotechnologies for cancer intervention: a patent review (2010-2016).Curcumin Targeted, Polymalic Acid-Based MRI Contrast Agent for the Detection of Aβ Plaques in Alzheimer's Disease.Covalent nano delivery systems for selective imaging and treatment of brain tumors.Distinct mechanisms of membrane permeation induced by two polymalic acid copolymers.Quantitative analysis of PMLA nanoconjugate components after backbone cleavage The optimization of polymalic acid peptide copolymers for endosomolytic drug delivery.Polymalic Acid Tritryptophan Copolymer Interacts with Lipid Membrane Resulting in Membrane Solubilization.HER2-positive breast cancer targeting and treatment by a peptide-conjugated mini nanodrug.Tuning polypeptide-based micellar carrier for efficient combination therapy of ErbB2-positive breast cancer.

P2860

Q28480835-46319E1A-DB5B-49ED-ABFB-AD4B93577FDB Q28829301-865E67DB-9FD5-4614-B403-A7B92B92412C Q29248327-1A5DCA43-3157-45B8-B547-88C66934AA75 Q30352890-009B6CA2-CAA4-4742-A2D7-90CC57FF437C Q33705431-11297BD2-6FD1-45BA-9135-F7B1AA2F771B Q33820964-7927ECB9-14AB-4576-83F1-CC336C0A7AB9 Q33864065-C86EC342-8F08-4188-8905-CA1094B43074 Q33987367-6DE36DD3-05B0-4F5E-9B16-A8E8F57D2C35 Q34499609-C2783B73-1854-4DBC-9382-27404BA77E47 Q35883670-08299DC2-A866-4F44-9C14-BA753CE60DC1 Q36321843-58EAF2CA-80F3-4106-ACD2-EB38678EE991 Q36406637-C064A274-3348-4D88-BC15-276C40F15AF6 Q36609101-69E7B2E6-681E-4ECF-A729-82A88126D17A Q36784555-3F2C5334-A2E8-44A8-A6D8-768A7FAAB41A Q36934007-E427CD97-090A-4B9B-B5C8-9F6349B598DF Q37046699-76351F08-056F-4196-AFA3-D783763A3871 Q37077422-1ED0AC62-619D-4115-BE03-687F05E2D409 Q37678070-318B55EC-51BE-483A-95EF-BE58B9A08F3D Q38183852-97D8BDC5-53DA-4CFD-9638-B02635927D2A Q38228137-97273F39-A1CB-4743-A46E-3139A488413A Q38233077-1AAB4A9F-1989-48BA-849E-E30DA80BB15B Q38494470-715695AD-4260-4E94-869C-CBFB206CE6AE Q38665261-60077AB4-B496-49DE-A8B0-44A447937C18 Q38670236-CDB09B8D-BF42-4E16-8792-AE53B908C454 Q39047248-582E740C-7D21-4F71-9270-B2D9BA9D8292 Q39367664-91DFE998-A79D-44AC-9390-64491B947B65 Q39537001-2376DD12-1A07-4BB1-AC96-97D0FECA6586 Q40458529-25611D65-FCB6-40BC-B117-CF9EF4D68D58 Q41922949-1B5419F5-A9FE-4BB6-9C2F-A8962029B370 Q42631516-2A0686E0-76B8-4A99-AE1D-BA1CA9871A14 Q49166356-3629E1C8-C91B-4323-A635-2030A14AD971 Q50223454-582FD7F8-25F7-4F2E-A4F2-97C6BC675AA7

P2860

Polymalic acid-based nanobiopolymer provides efficient systemic breast cancer treatment by inhibiting both HER2/neu receptor synthesis and activity.

http://www.wikidata.org/entity/Q36191573

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Polymalic acid-based nanobiopo ...... ceptor synthesis and activity.

@ast

Polymalic acid-based nanobiopo ...... ceptor synthesis and activity.

@en

type

label

Polymalic acid-based nanobiopo ...... ceptor synthesis and activity.

@ast

Polymalic acid-based nanobiopo ...... ceptor synthesis and activity.

@en

prefLabel

Polymalic acid-based nanobiopo ...... ceptor synthesis and activity.

@ast

Polymalic acid-based nanobiopo ...... ceptor synthesis and activity.

@en

P1433

Q36191573-28230FAF-4134-4835-A79D-F18E5E8D5DC4

P1476

Q36191573-D5615C9E-7E51-4EF1-A9FE-86838B3D4A3E

P2093

Q36191573-102B6ED6-D9CF-4F86-90ED-92C61D822FD5

Q36191573-17903E0E-D02E-4276-A07F-BE9061DF2753

Q36191573-2917C858-7163-4780-A417-F77C07620142

Q36191573-2CB0DF2E-9C4D-419F-A90F-AF3BFA47EF59

Q36191573-3892B184-9A73-4584-B934-2A8CF6E0D818

Q36191573-38CF61A6-A828-47DD-9416-DE337F58E55D

Q36191573-5EB029E0-9440-45E8-B38D-21F7DB7A267F

Q36191573-81CF92AC-B91C-440A-821A-B5DD2E96B227

Q36191573-8C50C7E3-F7F6-4EED-8467-6AF15FD8AF5C

Q36191573-912FB6A0-9C93-4B20-AEA5-384AD4F9DD09

P2860

Q36191573-0B284188-B16A-4D7E-AA20-D21D7AECB178

Q36191573-0F1F159F-3283-4D26-9C9F-F9254B9B3D0E

Q36191573-14EEB805-9141-4C36-9AE1-D721272EBF5D

Q36191573-1B2052E3-0711-4D71-A65E-201B964396CE

Q36191573-1FD9A33F-903E-4C45-AC90-6964B46D3C43

Q36191573-2557A75C-1D6E-421E-8D30-08E9E136ADA8

Q36191573-284AD284-B7B5-4716-9F6E-C68F5258F732

Q36191573-3C7A6EB6-6CFA-4698-9555-91BF462784C4

Q36191573-46069C59-0C30-4AB9-8709-7992EDAC64CB

Q36191573-4B7F374C-AE69-4D85-8B20-1B2057AA76F1

P304

Q36191573-4B24D708-6B7C-431A-B523-B52B18EE4B7E

P31

Q36191573-D2C6F0A7-1838-4F8C-A1C0-9A280DFE025D

P356

Q36191573-DE3A52F2-9C38-4235-AEEC-4D09800B9A22

P407

Q36191573-42AA26AC-C3CC-44A5-8772-7CFA46CD1D1F

P433

Q36191573-18B06131-FF67-4854-8097-45D411F99B43

P478

Q36191573-76DEE767-7C58-4DDE-A215-86C8C9AA5273

P577

Q36191573-3D27BCF3-885A-4492-984D-C0AA0F9CD19A

P5875

Q36191573-4EC45310-ABA3-49B6-9A96-337C26AA3968

P698

Q36191573-B7279F35-0979-4E70-804B-940E941D050A

P932

Q36191573-F62C1D7D-9FB5-4E33-B3E3-68BFEBC74C72

P356

0008-5472.CAN-10-3093

P1433

Cancer Research

P1476

Polymalic acid-based nanobiopo ...... ceptor synthesis and activity.

@en

P2093

Alexander V Ljubimov

http://www.w3.org/2001/XMLSchema#string

Andres Espinoza

http://www.w3.org/2001/XMLSchema#string

Bindu Konda

http://www.w3.org/2001/XMLSchema#string

Eggehard Holler

http://www.w3.org/2001/XMLSchema#string

Hui Ding

http://www.w3.org/2001/XMLSchema#string

Jinwei Hu

http://www.w3.org/2001/XMLSchema#string

Jose Portilla-Arias

http://www.w3.org/2001/XMLSchema#string

Julia Y Ljubimova

http://www.w3.org/2001/XMLSchema#string

Keith L Black

http://www.w3.org/2001/XMLSchema#string

Manabu Fujita

http://www.w3.org/2001/XMLSchema#string

P2860

Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Trastuzumab--mechanism of action and use in clinical practice

Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells.

Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance.

HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb

Inhibition of brain tumor growth by intravenous poly (β-L-malic acid) nanobioconjugate with pH-dependent drug release [corrected]

Pulmonary complications of novel antineoplastic agents for solid tumors.

Trastuzumab-associated cardiotoxicity.

Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate.

P304

1454-1464

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-10-3093

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49820066

http://www.w3.org/2001/XMLSchema#string

P698

21303974

http://www.w3.org/2001/XMLSchema#string

P932

3428373

http://www.w3.org/2001/XMLSchema#string